Skip to Content

Compugen's stock jumps after Bristol Myers Squibb completes $20 million investment into the company

Shares of Compugen Ltd. (CGEN.TV) gained 13.4% in premarket trading on Thursday after Bristol Myers Squibb Co. (BMY) completed a $20 million investment in the company. Compugen's stock is down 48.1% so far this year, while the broader S&P 500 is up 25.2%.

-Jaimy Lee


(END) Dow Jones Newswires

11-11-21 0822ET

Copyright (c) 2021 Dow Jones & Company, Inc.